JP2009535334A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009535334A5 JP2009535334A5 JP2009507739A JP2009507739A JP2009535334A5 JP 2009535334 A5 JP2009535334 A5 JP 2009535334A5 JP 2009507739 A JP2009507739 A JP 2009507739A JP 2009507739 A JP2009507739 A JP 2009507739A JP 2009535334 A5 JP2009535334 A5 JP 2009535334A5
- Authority
- JP
- Japan
- Prior art keywords
- triazolo
- isoquinolin
- benzo
- alkyl
- aminopropyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US79469406P | 2006-04-25 | 2006-04-25 | |
| US60/794,694 | 2006-04-25 | ||
| PCT/US2007/009643 WO2007127138A1 (en) | 2006-04-25 | 2007-04-20 | Triazoloquinazolinone derivatives as inhibitors of checkpoint kinases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009535334A JP2009535334A (ja) | 2009-10-01 |
| JP2009535334A5 true JP2009535334A5 (enExample) | 2010-10-14 |
| JP5229221B2 JP5229221B2 (ja) | 2013-07-03 |
Family
ID=38441857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009507739A Expired - Fee Related JP5229221B2 (ja) | 2006-04-25 | 2007-04-20 | チェックポイント・キナーゼのインヒビターとしてのトリアゾロキナゾリノン誘導体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7501435B2 (enExample) |
| EP (1) | EP2013212A1 (enExample) |
| JP (1) | JP5229221B2 (enExample) |
| AR (1) | AR060619A1 (enExample) |
| AU (1) | AU2007243520B2 (enExample) |
| CA (1) | CA2649811A1 (enExample) |
| DO (1) | DOP2007000082A (enExample) |
| TW (1) | TW200806670A (enExample) |
| WO (1) | WO2007127138A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1836807A2 (en) * | 2005-01-06 | 2007-09-26 | Merck & Co., Inc. | Inhibitors of checkpoint kinases |
| AU2006203963A1 (en) * | 2005-01-06 | 2006-07-13 | Merck Sharp & Dohme Corp. | Inhibitors of checkpoint kinases |
| US7550477B2 (en) | 2006-01-04 | 2009-06-23 | Merck & Co., Inc. | Inhibitors of checkpoint kinases |
| WO2009099601A2 (en) * | 2008-02-04 | 2009-08-13 | Dana-Farber Cancer Institute, Inc. | Chk1 suppresses a caspase-2 apoptotic response to dna damage that bypasses p53, bcl-2 and caspase-3 |
| CA2714087A1 (en) * | 2008-02-14 | 2009-08-20 | Merck Sharp & Dohme Corp. | Inhibitors of checkpoint kinases |
| EP2406250B1 (en) * | 2009-03-11 | 2015-08-12 | Merck Sharp & Dohme Corp. | Inhibitors of akt activity |
| US20140134178A1 (en) * | 2012-01-06 | 2014-05-15 | H. Lee Moffit Cancer Center And Research Institute | Phosphorylation of histones and uses thereof |
| CA2928568A1 (en) | 2013-07-26 | 2015-01-29 | Update Pharma Inc. | Combinatorial methods to improve the therapeutic benefit of bisantrene |
| TW201702218A (zh) | 2014-12-12 | 2017-01-16 | 美國杰克森實驗室 | 關於治療癌症、自體免疫疾病及神經退化性疾病之組合物及方法 |
| WO2020204024A1 (ja) * | 2019-04-03 | 2020-10-08 | テラ・ストーン株式会社 | チミン核酸塩基をベースとするトリアゾロピリミジン類及びその製造方法 |
| CN113966336B (zh) | 2019-06-06 | 2023-11-07 | 和记黄埔医药（上海）有限公司 | 三环类化合物及其用途 |
| CN115197225B (zh) * | 2021-09-03 | 2023-04-11 | 贵州大学 | 一种五元杂环并喹唑啉酮类化合物及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1244501A (en) * | 1968-03-09 | 1971-09-02 | Aspro Nicholas Ltd | Heterocyclic amines |
| RU2145606C1 (ru) * | 1994-05-24 | 2000-02-20 | Ф.Хоффманн-Ля Рош Аг | Трициклические дикарбонильные производные и лекарственный препарат на их основе |
| US5677309A (en) * | 1996-03-22 | 1997-10-14 | Neurogen Corporation | 1,2,4-triazolo 4,3-c! quinazolin-3-ones and 1,2,4-triazolo 4,3-c!quinazolin-3-thiones; a new class of GABA brain receptor ligands |
| AU2004220176A1 (en) * | 2003-03-14 | 2004-09-23 | Astrazeneca Ab | Novel fused triazolones and the uses thereof |
| PL1898903T3 (pl) * | 2005-06-10 | 2013-08-30 | Merck Sharp & Dohme | Inhibitory aktywności Akt |
| US7550477B2 (en) | 2006-01-04 | 2009-06-23 | Merck & Co., Inc. | Inhibitors of checkpoint kinases |
-
2007
- 2007-04-17 TW TW096113500A patent/TW200806670A/zh unknown
- 2007-04-20 JP JP2009507739A patent/JP5229221B2/ja not_active Expired - Fee Related
- 2007-04-20 CA CA002649811A patent/CA2649811A1/en not_active Abandoned
- 2007-04-20 WO PCT/US2007/009643 patent/WO2007127138A1/en not_active Ceased
- 2007-04-20 AU AU2007243520A patent/AU2007243520B2/en not_active Ceased
- 2007-04-20 EP EP07755786A patent/EP2013212A1/en not_active Withdrawn
- 2007-04-20 AR ARP070101718A patent/AR060619A1/es not_active Application Discontinuation
- 2007-04-24 US US11/789,288 patent/US7501435B2/en not_active Expired - Fee Related
- 2007-04-25 DO DO2007000082A patent/DOP2007000082A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009535334A5 (enExample) | ||
| JP2017505762A5 (enExample) | ||
| JP2018536671A5 (enExample) | ||
| CN114846005A (zh) | Shp2抑制剂及其应用 | |
| JP2010509356A5 (enExample) | ||
| JP2009532464A5 (enExample) | ||
| JP2010504344A5 (enExample) | ||
| EP2920177A1 (en) | Compounds and compositions for the treatment of parasitic diseases | |
| JP2005513082A5 (enExample) | ||
| JP2014525432A5 (enExample) | ||
| JP2016525075A5 (enExample) | ||
| JP2017537960A5 (enExample) | ||
| JP2017510576A5 (enExample) | ||
| CA2651363A1 (en) | Triazolopyrazine derivatives useful as anti-cancer agents | |
| JP2020502230A5 (enExample) | ||
| JP2014513139A5 (enExample) | ||
| PE20141938A1 (es) | Nuevos compuestos inhibidores de la fosfodiesterasa del tipo 10a | |
| HRP20201469T1 (hr) | Derivati tetrahidroizokinolina | |
| PE20090370A1 (es) | Derivados de heterociclo fusionado como inhibidores de quinasa | |
| JP2018535211A5 (enExample) | ||
| JP2014513140A5 (enExample) | ||
| JP2017520607A5 (enExample) | ||
| JP2014521662A5 (enExample) | ||
| JP2016505010A5 (enExample) | ||
| JP2016514719A5 (enExample) |